Literature DB >> 31681453

Bayesian Semiparametric Joint Regression Analysis of Recurrent Adverse Events and Survival in Esophageal Cancer Patients.

Juhee Lee1, Peter F Thall2, Steven H Lin3.   

Abstract

We propose a Bayesian semiparametric joint regression model for a recurrent event process and survival time. Assuming independent latent subject frailties, we define marginal models for the recurrent event process intensity and survival distribution as functions of the subject's frailty and baseline covariates. A robust Bayesian model, called Joint-DP, is obtained by assuming a Dirichlet process for the frailty distribution. We present a simulation study that compares posterior estimates under the Joint-DP model to a Bayesian joint model with lognormal frailties, a frequentist joint model, and marginal models for either the recurrent event process or survival time. The simulations show that the Joint-DP model does a good job of correcting for treatment assignment bias, and has favorable estimation reliability and accuracy compared with the alternative models. The Joint-DP model is applied to analyze an observational dataset from esophageal cancer patients treated with chemo-radiation, including the times of recurrent effusions of fluid to the heart or lungs, survival time, prognostic covariates, and radiation therapy modality.

Entities:  

Keywords:  Accelerated Failure Time; Bayesian nonparametrics; Chemoradiation; Dirichlet process; Esophageal cancer; Joint model; Nonhomogeneous Point process

Year:  2019        PMID: 31681453      PMCID: PMC6824476          DOI: 10.1214/18-AOAS1182

Source DB:  PubMed          Journal:  Ann Appl Stat        ISSN: 1932-6157            Impact factor:   2.083


  33 in total

1.  Doubly robust estimation in missing data and causal inference models.

Authors:  Heejung Bang; James M Robins
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

2.  Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach.

Authors:  C L Faucett; D C Thomas
Journal:  Stat Med       Date:  1996-08-15       Impact factor: 2.373

3.  Bayesian Semi-parametric Analysis of Semi-competing Risks Data: Investigating Hospital Readmission after a Pancreatic Cancer Diagnosis.

Authors:  Kyu Ha Lee; Sebastien Haneuse; Deborah Schrag; Francesca Dominici
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2015-02-01       Impact factor: 1.864

4.  Joint scale-change models for recurrent events and failure time.

Authors:  Gongjun Xu; Sy Han Chiou; Chiung-Yu Huang; Mei-Cheng Wang; Jun Yan
Journal:  J Am Stat Assoc       Date:  2017-04-12       Impact factor: 5.033

5.  Modelling progression of CD4-lymphocyte count and its relationship to survival time.

Authors:  V De Gruttola; X M Tu
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

6.  Bayesian Nonparametric Estimation for Dynamic Treatment Regimes with Sequential Transition Times.

Authors:  Yanxun Xu; Peter Müller; Abdus S Wahed; Peter F Thall
Journal:  J Am Stat Assoc       Date:  2016-10-18       Impact factor: 5.033

7.  Hierarchical models for semi-competing risks data with application to quality of end-of-life care for pancreatic cancer.

Authors:  Kyu Ha Lee; Francesca Dominici; Deborah Schrag; Sebastien Haneuse
Journal:  J Am Stat Assoc       Date:  2016-10-18       Impact factor: 5.033

8.  CENTER-ADJUSTED INFERENCE FOR A NONPARAMETRIC BAYESIAN RANDOM EFFECT DISTRIBUTION.

Authors:  Yisheng Li; Peter Müller; Xihong Lin
Journal:  Stat Sin       Date:  2011       Impact factor: 1.261

9.  A Bayesian multivariate joint frailty model for disease recurrences and survival.

Authors:  Sijin Wen; Xuelin Huang; Ralph F Frankowski; Janice N Cormier; Peter Pisters
Journal:  Stat Med       Date:  2016-07-06       Impact factor: 2.373

10.  Influence of body mass index on the long-term outcomes of patients with esophageal squamous cell carcinoma who underwent esophagectomy as a primary treatment: A 10-year medical experience.

Authors:  Wenhao Ji; Weihui Zheng; Bo Li; Caineng Cao; Weimin Mao
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.